drugset / Trial / NCT00910533

Study on Early Lyme Neuroborreliosis

NCT00910533

Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to determine clinical course and the sequelae of early Lyme neuroborreliosis after treatment with ceftriaxone.

Timeline

Start
2009-01-01
Primary completion
2018-12-31
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ceftriaxone Other / unclassified 2 g Intravenous

Indications